Skip Navigation

Cardiovascular Research 2000 45(4):883-888; doi:10.1016/S0008-6363(99)00415-0
© 2000 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Takeishi, Y.
Right arrow Articles by Walsh, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takeishi, Y.
Right arrow Articles by Walsh, R. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2000, European Society of Cardiology

Alterations in Ca2+ cycling proteins and G{alpha}q signaling after left ventricular assist device support in failing human hearts

Yasuchika Takeishia, Thunder Jalilib, Brian D. Hoita, Darryl L. Kirkpatricka, Lynne E. Wagonerc, William T. Abrahamc and Richard A. Walsha,*

aDepartment of Medicine, Case Western Reserve University and University Hospitals of Cleveland, 11100 Euclid Avenue Cleveland, OH 44106-5029, USA
bUniversity of Utah, Salt Lake City, UT, USA
cUniversity of Cincinnati, Cincinnati, OH, USA

* Corresponding author. Tel.: +1-216-844-3293; fax: +1-216-844-3145 raw19{at}po.cwru.edu

Objective: Left ventricular assist device support mechanically unloads the failing ventricle with resultant improvement in cardiac geometry and function in patients with end-stage heart failure. Activation of the G{alpha}q signaling pathway, including protein kinase C, appears to be involved in the progression of heart failure. Similarly down-regulation of Ca2+ cycling proteins may contribute to contractile depression in this clinical syndrome. Thus we examined whether protein kinase C activation and decreased Ca2+ cycling protein levels could be reversed by left ventricular assist device support. Methods: Left ventricular myocardial specimens were obtained from seven patients during placement of left ventricular assist device and heart transplantation. We examined changes in protein levels of G{alpha}q, phospholipase C β1, regulators of G protein signaling (RGS), sarcoplasmic reticulum Ca2+ ATPase, phospholamban and translocation of protein kinase C isoforms ({alpha}, β1, and β2). Results: The paired pre- and post- left ventricular assist device samples revealed that RGS2, a selective inhibitor of G{alpha}q, was decreased (P<0.01), while the status of G{alpha}q, phospholipase C β1, RGS3 and RGS4 were unchanged after left ventricular assist device implantation. Translocation of protein kinase C isoforms remained unchanged. Left ventricular assist device support increased sarcoplasmic reticulum Ca2+ ATPase protein level (P<0.01), while phospholamban abundance was unchanged. Conclusions: We conclude that altered protein expression and stoichiometry of the major cardiomyocyte Ca2+ cycling proteins rather than reduced phospholipase C β1 activation may contribute to improved mechanical function produced by left ventricular assist device support in human heart failure.

KEYWORDS G-proteins; Heart failure; Protein kinases; Signal transduction; Transplantation


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
M. Vanderheyden, W. Mullens, L. Delrue, M. Goethals, B. de Bruyne, W. Wijns, P. Geelen, S. Verstreken, F. Wellens, and J. Bartunek
Myocardial Gene Expression in Heart Failure Patients Treated With Cardiac Resynchronization Therapy: Responders Versus Nonresponders
J. Am. Coll. Cardiol., January 15, 2008; 51(2): 129 - 136.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. van der Velden, N. A. Narolska, R. R. Lamberts, N. M. Boontje, A. Borbely, R. Zaremba, J. G.F. Bronzwaer, Z. Papp, K. Jaquet, W. J. Paulus, et al.
Functional effects of protein kinase C-mediated myofilament phosphorylation in human myocardium
Cardiovasc Res, March 1, 2006; 69(4): 876 - 887.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
E. L. Riddle, R. A. Schwartzman, M. Bond, and P. A. Insel
Multi-Tasking RGS Proteins in the Heart: The Next Therapeutic Target?
Circ. Res., March 4, 2005; 96(4): 401 - 411.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
X. T. Gan, V. Rajapurohitam, J. V. Haist, P. Chidiac, M. A. Cook, and M. Karmazyn
Inhibition of Phenylephrine-Induced Cardiomyocyte Hypertrophy by Activation of Multiple Adenosine Receptor Subtypes
J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 27 - 34.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
J. L. Hall, S. Grindle, X. Han, D. Fermin, S. Park, Y. Chen, R. J. Bache, A. Mariash, Z. Guan, S. Ormaza, et al.
Genomic profiling of the human heart before and after mechanical support with a ventricular assist device reveals alterations in vascular signaling networks
Physiol Genomics, May 19, 2004; 17(3): 283 - 291.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. K. F. Hon and M. H. Yacoub
Bridge to recovery with the use of left ventricular assist device and clenbuterol
Ann. Thorac. Surg., June 1, 2003; 75(90060): S36 - 41.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
X. Chen, V. Piacentino III, S. Furukawa, B. Goldman, K. B. Margulies, and S. R. Houser
L-Type Ca2+ Channel Density and Regulation Are Altered in Failing Human Ventricular Myocytes and Recover After Support With Mechanical Assist Devices
Circ. Res., September 20, 2002; 91(6): 517 - 524.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
S. Hollinger and J. R. Hepler
Cellular Regulation of RGS Proteins: Modulators and Integrators of G Protein Signaling
Pharmacol. Rev., September 1, 2002; 54(3): 527 - 559.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. Mittmann, C. H. Chung, G. Hoppner, C. Michalek, M. Nose, C. Schuler, A. Schuh, T. Eschenhagen, J. Weil, B. Pieske, et al.
Expression of ten RGS proteins in human myocardium: functional characterization of an upregulation of RGS4 in heart failure
Cardiovasc Res, September 1, 2002; 55(4): 778 - 786.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. Takeishi, Q. Huang, J.-i. Abe, W. Che, J.-D. Lee, H. Kawakatsu, B. D Hoit, Bradford.C Berk, and R. A Walsh
Activation of mitogen-activated protein kinases and p90 ribosomal S6 kinase in failing human hearts with dilated cardiomyopathy
Cardiovasc Res, January 1, 2002; 53(1): 131 - 137.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. L. Ogletree-Hughes, L. B. Stull, W. E. Sweet, N. G. Smedira, P. M. McCarthy, and C. S. Moravec
Mechanical Unloading Restores {beta}-Adrenergic Responsiveness and Reverses Receptor Downregulation in the Failing Human Heart
Circulation, August 21, 2001; 104(8): 881 - 886.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. S. Kumpati, P. M. McCarthy, and K. J. Hoercher
Left ventricular assist device bridge to recovery: a review of the current status
Ann. Thorac. Surg., March 1, 2001; 71 (2007): S103 - S108.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. Z. Feuerstein and D. Rozanski
G Proteins and Heart Failure : Is G{alpha}q a Novel Target for Heart Failure?
Circ. Res., December 8, 2000; 87(12): 1085 - 1086.
[Full Text] [PDF]


Home page
CirculationHome page
P. M. Heerdt, J. W. Holmes, B. Cai, A. Barbone, J. D. Madigan, S. Reiken, D. L. Lee, M. C. Oz, A. R. Marks, and D. Burkhoff
Chronic Unloading by Left Ventricular Assist Device Reverses Contractile Dysfunction and Alters Gene Expression in End-Stage Heart Failure
Circulation, November 28, 2000; 102(22): 2713 - 2719.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.